Tom Fleming
Question:740 Deputy Tom Fleming asked the Minister for Health if the cystic fibrosis drug kayldeco is covered under the medical card scheme; and if he will make a statement on the matter. [34448/12]
View answerDáil Éireann Debate, Tuesday - 17 July 2012
740 Deputy Tom Fleming asked the Minister for Health if the cystic fibrosis drug kayldeco is covered under the medical card scheme; and if he will make a statement on the matter. [34448/12]
View answer741 Deputy Tom Fleming asked the Minister for Health if the cystic fibrosis drug kayldeco is covered under the long-term illness scheme; and if he will make a statement on the matter. [34449/12]
View answerI propose to take Questions Nos. 740 and 741 together.
Ivacaftor (Kalydeco) received a positive opinion from the Committee for Medicinal Products for Human Use at EU level in May 2012. Marketing authorisation issued by the EU Commission is anticipated in due course. Should the manufacturers make an application for inclusion of the product on the GMS and community drugs schemes, that application shall be considered in accordance with the relevant criteria.